1. Medtech Insight
  2. >>Policy & Regulation

Self-Referral Drives Extra Prostate Biopsy Activity, Study Suggests

A Medicare claims analysis compared biopsy trends in men referred for biopsy analysis by urologists who use a pathology lab to which they have a financial association, and those who see urologists that order biopsies at unassociated labs.

Researchers reported data this month suggesting self-referring urologists frequently submit additional biopsy samples compared to non-self-referring doctors and more often perform biopsies on men less likely to have a positive diagnosis of prostate cancer.

The study was published by Jean Mitchell, professor of public policy at Georgetown University, in the April issue of the health policy journal Health Affairs and was presented April 12...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Policy & Regulation

More from Medtech Insight

TRiCares Tricuspid Valve Replacement System Reduces Regurgitation In First-In-Human Study

 
• By Natasha Barrow

TRiCares presented data from the first-in-human study for its tricuspid valve replacement system – Topaz – at EuroPCR 2025 on 22 May.

Swiss Medtechs Advised To Work On US Tariff Mitigation Strategies

 
• By Ashley Yeo

The US’ 90-day suspension of higher “reciprocal tariffs” will expire on 9 July, raising fears that the 31% tariff rate on Swiss medtech and other goods exported to the US might make a comeback. While the tariff situation changes on an almost daily basis, medtechs should forearm for any eventually, say local business organizations.

Guardant Health Launches Germline Hereditary Cancer Test

 
• By Natasha Barrow

Guardant Health introduces a new germline panel test to help guide cancer treatment, assess the risk of secondary cancers in patients and identify family members at risk of cancer.